Asia-Pacific markets fall as investors await India rate decision, assess Japan’s spending data

Asia-Pacific markets fall as investors await India rate decision, assess Japan’s spending data


Japan’s household spending massively beats expectations, boosting case for further BOJ hikes

Japan’s household spending in December rose 2.7% year on year in real terms, according to a Friday report from the Statistics Bureau of Japan, massively beating expectations from economists polled by Reuters and marking its first rise since July 2024.

The figure sharply beat Reuters expectations of a 0.2% rise, boosting the case for another interest rate hike from the Bank of Japan.

The data comes after the BOJ in January raised its benchmark policy rate to 0.5%, its highest since 2008. The BOJ has long stated that it would raise rates if it sees a “virtuous cycle” of higher prices and growing wages.

Read the full story here.

—Lim Hui Jie

S&P 500, Nasdaq close higher

The S&P 500 and Nasdaq Composite finished Thursday’s session in positive territory.

The broad market index gained 0.36% to close at 6,083.57, while the tech-heavy Nasdaq climbed 0.51% to finish at 19,791.99. Meanwhile, the blue-chip Dow Jones Industrial Average fell 125.65 points, or 0.28%, to settle at 44,747.63.

— Sean Conlon

UBS sees gold prices climbing to new all-time highs going forward

Tariff concerns have already sent gold prices to fresh all-time highs this week, but UBS believes the precious metal could advance even higher in valuation.

In a Friday note, UBS raised its gold forecasts to $3,000 per ounce over the next 12 months. Spot gold was last trading $2,849.89 per ounce after hitting an all-time high of $2,882.16 on Wednesday.

“Our base case remains that significant tariffs against Canada and Mexico are unlikely to be sustained for a prolonged period, and that the ratcheting up of the U.S.’s effective tariff rate on China to 30% will be gradual,” UBS wrote. “But, we also believe gold will continue to be supported throughout the year by elevated uncertainty, an extension of the global rate-cutting cycle, and strong investor and central bank demand.”

“Direct exposure to the metal may dampen risk in portfolios,” the bank added. “Equities linked to gold (such as gold miners) may offer greater capital gains potential but are likely to be more volatile and act like equities in times of risk aversion. We believe gold and the means to invest in it (directly or indirectly) should form part of a well-diversified portfolio,” the note said.

— Lisa Kailai Han



Source

Google joins Microsoft in telling users Anthropic is still available outside defense projects
World

Google joins Microsoft in telling users Anthropic is still available outside defense projects

Google CEO Sundar Pichai gestures to the crowd during Google’s annual I/O developers conference in Mountain View, California, on May 20, 2025. David Paul Morris | Bloomberg | Getty Images Google said it will continue offering Anthropic’s artificial intelligence technology for clients, excluding for defense work, a day after Microsoft issued a similar statement to […]

Read More
Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide
World

Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide

The U.S. and Israel are showing signs of escalating their war against Iran – a move that could batter a variety of assets, even traditional safe havens. To protect their portfolios, investors can snap up stocks from an oft-shorted sector: pharmaceuticals, UBS analysts say. Since the first strikes last Saturday, the Iran War has roiled […]

Read More
Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’
World

Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’

Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults and adolescents. (Photo by Steve Christo – Corbis/Corbis via Getty Images) Steve Christo – Corbis | Corbis News | Getty Images The chief executive of drugmaker Zealand Pharma sought to calm investors about the latest […]

Read More